Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
66.07
-1.63 (-2.41%)
At close: Aug 20, 2025, 4:00 PM
67.48
+1.41 (2.13%)
After-hours: Aug 20, 2025, 7:47 PM EDT
Claritev Market Cap
Claritev has a market cap or net worth of $1.09 billion as of August 20, 2025. Its market cap has increased by 501.82% in one year.
Market Cap
1.09B
Enterprise Value
5.69B
1-Year Change
501.82%
Ranking
Category
Stock Price
$66.07
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $1.09B, an increase of 347.94%. That is a compound annual growth rate of 32.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 1.09B | 355.42% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 631.30B |
| Johnson & Johnson | 428.20B |
| AbbVie | 364.25B |
| UnitedHealth Group | 275.54B |
| AstraZeneca | 246.71B |
| Novartis AG | 242.21B |
| Novo Nordisk | 241.79B |
| Abbott Laboratories | 228.44B |